Mepolizumab for eosinophilic chronic sinusitis with nasal polyposis: real-life experience.

Kassem, F; Cohen-Confino, R; Meir-Shafrir, K; Lachover-Roth, I; Cohen-Engler, A; Nageris, B; Rosman, Y

Kassem, F; Cohen-Confino, R; Meir-Shafrir, K; Lachover-Roth, I; Cohen-Engler, A; Nageris, B; Rosman, Y.

Afiliación

Kassem F; ENT department, Meir medical center, Israel; Sackler school of medicine, Tel-Aviv university, Israel.
Cohen-Confino R; Sackler school of medicine, Tel-Aviv university, Israel; Allergy and clinical immunology unit, Meir medical center, Israel.
Meir-Shafrir K; Allergy and clinical immunology unit, Meir medical center, Israel.
Lachover-Roth I; Sackler school of medicine, Tel-Aviv university, Israel; Allergy and clinical immunology unit, Meir medical center, Israel.
Cohen-Engler A; Sackler school of medicine, Tel-Aviv university, Israel; Allergy and clinical immunology unit, Meir medical center, Israel.
Nageris B; ENT department, Meir medical center, Israel;Sackler school of medicine, Tel-Aviv university, Israel.
Rosman Y; Sackler school of medicine, Tel-Aviv university, Israel; Allergy and clinical immunology unit, Meir medical center, Israel.

Rhinology ; 59(1): 110-112, 2021 02 01.

Article en En | MEDLINE | ID: mdl-33320921

Asunto(s)

Pólipos Nasales; Sinusitis; Anticuerpos Monoclonales Humanizados; Enfermedad Crónica; Humanos; Pólipos Nasales/tratamiento farmacológico; Sinusitis/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sinusitis / Pólipos Nasales Límite: Humans Idioma: En Revista: Rhinology Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google